Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fonar CEO disputes MRI Nobel

This article was originally published in The Gray Sheet

Executive Summary

2003 Nobel Prize in physiology or medicine awarded to Paul Lauterbur, MD, University of Illinois, for discovering "the possibility to create a two-dimensional picture by introducing gradients in the magnetic field," and Peter Mansfield, MD, University of Nottingham in Britain, for demonstrating "how the [gradients] could be mathematically analyzed, which made it possible to develop a useful imaging technique." The prize is strongly contested by Fonar founder and CEO Raymond Damadian, MD, who has taken out full-page ads in newspapers such as the Washington Post, insisting he deserves a third of the $1.3 mil. award for making initial discoveries enabling MRI technology. The Post ad, which cost approximately $84,000, accuses the Nobel Committee of "attempting to rewrite history." Fonar manufactures the Stand-Up MRI, distributed by GE Medical Systems. Roughly 57 systems have been sold to date...

You may also be interested in...



What Lies Ahead: COVID-19 Vaccination Challenges

The director of adult immunizations at Johns Hopkins International Vaccine Access Center talks to Scrip about undertaking a massive COVID-19 vaccination effort in the US.

P&G: Sales Growth Strongest When Rising Tide Floats All Competitors Across All Categories

P&G’s oral care business drove 35% of total category market growth in the firm’s fiscal 2020 and exemplifies its growth strategy for all segments – grow entire categories rather than take competitors’ market share, says CFO Jon Moeller.

COVID-19 Vaccine 'Brexit Bonus' A Myth

The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.

UsernamePublicRestriction

Register

OM002409

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel